신약 개발 정보학 시장 규모와 예측(2021-2031년) - 세계 및 지역별 점유율, 동향, 성장 기회 분석 보고서 : 워크플로우별, 서비스별, 솔루션별, 최종사용자별, 지역별
Drug Discovery Informatics Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Workflow, Service, Solution, End User, and Geography
상품코드
:
1906673
리서치사
:
The Insight Partners
발행일
:
2025년 11월
페이지 정보
:
영문 200 Pages
샘플 요청 목록에 추가
세계 신약 개발 정보학 시장은 2024년 33억 9,000만 달러로 평가되었고, 2031년까지 81억 7,000만 달러에 달할 것으로 예측됩니다. 신약개발 정보학 시장 규모는 2025년부터 2031년까지 13.7%의 연평균 복합 성장률(CAGR)을 보일 것으로 추정됩니다.
세계의 신약 개발 정보학 시장은 연구개발 활동 증가, 표적치료에 수요, 데이터 분석 기술 진보에 촉진 되어 예측 기간 중에 현저한 성장이 전망됩니다.미국, 독일, 일본, 중국등의 국가가 이 변화를 주도하고 있어, 신속한 의약품 개발 필요성, 약제 스크리닝 정도 향상, 연구 비용 절감이 추진력이 되고 있습니다.AI와 머신러닝을 신약 개발 정보학 플랫폼에 통합하는 것으로, 생물학적·화학적 데이터 실시간 분석이 가능해져, Drug Discovery 프로세스 전체 의사결정과 생산성이 향상하고 있습니다.
제약사들은 신약 개발 정보학을 활용하여 히트 화합물 발굴, 리드 화합물 최적화, 예측 모델링을 통해 유망한 신약 후보물질을 빠르게 발굴할 수 있도록 지원하고 있습니다. 이는 시장 출시 시간이 매우 중요한 종양학, 신경학, 감염학 등의 치료 영역에서 특히 중요합니다. 고급 정보학 도구는 유전체 데이터 분석과 바이오마커 발견을 촉진함으로써 개인 맞춤형 의료의 확대 추세를 뒷받침하고 있습니다.
또한, 공동연구 모델의 확대, 제약기업과 기술기업 간의 전략적 제휴, 정부의 지원정책이 시장 보급을 가속화하고 있습니다. 헬스케어 수요 증가, 고령화 사회의 진전, 연구 방법의 효율화 추진을 배경으로 신약개발 인포매틱스는 전 세계 의약품 개발의 변화에서 핵심적인 역할을 하고 있습니다. 민관 협력과 바이오메디컬 혁신에 대한 자금 증가도 신약개발 인포매틱스 시장의 견조한 성장에 기여하고 있습니다.
목차 제1장 도입
제2장 주요 요약
제3장 조사 방법
2차 조사
1차 조사
가설 책정
거시경제적 요인 분석
기준치 산출
데이터 삼각측량
국가 레벨 데이터
전제조건과 제한 사항
제4장 신약 개발 정보학 시장 구도
PEST 분석
생태계 분석
플랫폼 제공 기업 및 기술 혁신 기업
제약 기업 및 바이오테크놀러지 기업
규제기관 및 민관 파트너십
밸류체인 벤더 리스트
제5장 신약 개발 정보학 시장 - 주요 시장 역학
신약 개발 정보학 시장 - 주요 시장 역학
성장 촉진요인
성장 억제요인
기회
동향
성장 촉진요인과 억제요인의 영향
제6장 신약 개발 정보학 시장 - 세계 시장 분석
신약 개발 정보학 시장 매출, 2021-2031년
신약 개발 정보학 시장 예측 분석
제7장 신약 개발 정보학 시장 분석 - 워크플로우별
Drug Discovery 인포매틱스
Drug Discovery 개발
제8장 신약 개발 정보학 시장 분석 - 서비스별
배열 분석 플랫폼
분자 모델링
임상시험 데이터 관리
도킹
기타
제9장 신약 개발 정보학 시장 분석 - 솔루션별
제10장 신약 개발 정보학 시장 분석 - 최종사용자별
제약회사 및 바이오테크놀러지 기업
수탁 연구기관(CRO)
기타
제11장 신약 개발 정보학 시장 - 지역 분석
북미
유럽
독일
영국
프랑스
이탈리아
러시아
기타 유럽 국가
아시아태평양
중국
일본
인도
호주
한국
아시아태평양 기타 국가
중동 및 아프리카
아라비아
남아프리카공화국
아랍에미리트(UAE)
기타 중동 및 아프리카
남미 및 중남미
제12장 경쟁 구도
주요 기업별 히트맵 분석
기업 점유율 분석(2024년)
제13장 업계 상황
시장 이니셔티브
제품 개발
인수합병(M&A)
파트너십 및 협업
사업 확대
제14장 기업 개요
Jubilant Pharma Limited
Certera
Thermo Fisher Scientific Inc.
Dassault Systemes SE
Revvity Inc
Selvita
Eurofins Scientific SE
Collaborative Drug Discovery, Inc.
Charles River Laboratories International Inc
Illumina, Inc
제15장 부록
LSH
영문 목차
The global drug discovery informatics Market was valued at US$ 3.39 billion in 2024 and is expected to reach US$ 8.17 billion by 2031. The Drug Discovery Informatics market size is estimated to register a CAGR of 13.7% during 2025-2031.
The global drug discovery informatics market is expected to grow significantly during the forecast period, driven by increasing R&D activities, demand for targeted therapies, and technological advancements in data analytics. Countries such as the United States, Germany, Japan, and China are leading this shift, propelled by the need for faster drug development, improved accuracy in drug screening, and reduced research costs. The integration of AI and machine learning into Drug Discovery Informatics platforms is enabling real-time analysis of biological and chemical data, enhancing decision-making and productivity across the drug discovery pipeline.
Pharmaceutical companies are leveraging drug discovery informatics for hit identification, lead optimization, and predictive modeling, which supports quicker identification of promising drug candidates. This is particularly important in therapeutic areas such as oncology, neurology, and infectious diseases, where time-to-market is critical. Advanced informatics tools are also supporting the growing trend of personalized medicine by facilitating genomic data analysis and biomarker discovery.
Additionally, the expansion of collaborative research models, strategic alliances between pharma and tech companies, and supportive government initiatives are accelerating market adoption. With rising healthcare demands, aging populations, and the push toward more efficient research processes, Drug Discovery Informatics is playing a central role in transforming drug development worldwide. Public-private partnerships and increased funding in biomedical innovation are also contributing to the robust growth of the Drug Discovery Informatics market.
Jubilant Pharma Limited., Certera., Thermo Fisher Scientific Inc., Dassault Systemes SE, Revvity Inc., Selvita., Eurofins Scientific SE., Collaborative Drug Discovery, Inc., and Charles River Laboratories International Inc are among the key global drug discovery informatics market players that are profiled in this market study.
The overall global drug discovery informatics market size has been derived using both primary and secondary sources. Exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the global drug discovery informatics market size. The process also helps obtain an overview and forecast of the market with respect to all the market segments. Also, multiple primary interviews have been conducted with industry participants to validate the data and gain analytical insights. This process includes industry experts such as VPs, business development managers, market intelligence managers, and national sales managers, along with external consultants such as valuation experts, research analysts, and key opinion leaders, specializing in the global drug discovery informatics market.
Table Of Contents 1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Analyst Market Outlook
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
3.3 Assumptions and Limitations
4. Drug Discovery Informatics Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
4.3.1 Platform Providers & Technology Innovators:
4.3.2 Pharmaceutical & Biotechnology Companies:
4.3.3 Regulatory Agencies & Public-Private Partnerships:
4.3.4 List of Vendors in Value Chain
5. Drug Discovery Informatics Market - Key Market Dynamics
5.1 Drug Discovery Informatics Market - Key Market Dynamics
5.2 Drivers
5.2.1 Rise in Prevalence of Chronic Diseases
5.2.2 Advancements in Personalized Medicine
5.2.3 Surge in Government and Institutional Funding
5.3 Restraints
5.3.1 High Implementation and Licensing Costs
5.3.2 Shortage of Skilled Professionals
5.3.3 Data Privacy and Security Concerns
5.4 Opportunities
5.4.1 Increase in Adoption of Cloud-Based Solutions
5.4.2 Advancements in Genomics and Biotechnology
5.4.3 Rise in Demand for Biologics
5.5 Trends
5.5.1 Integration of Artificial Intelligence and Machine Learning
5.5.2 Adoption of Real-World Evidence (RWE) and Real-World Data (RWD)
5.5.3 Utilization of Automation and Robotics
5.6 Impact of Drivers and Restraints:
6. Drug Discovery Informatics Market - Global Market Analysis
6.1 Drug Discovery Informatics Market Revenue (US$ Million), 2021-2031
6.2 Drug Discovery Informatics Market Forecast Analysis
7. Drug Discovery Informatics Market Analysis - by Workflow
7.1 Discovery Informatics
7.1.1 Overview
7.1.2 Discovery Informatics: Drug Discovery Informatics Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Drug Development
7.2.1 Overview
7.2.2 Drug Development: Drug Discovery Informatics Market - Revenue and Forecast to 2031 (US$ Million)
8. Drug Discovery Informatics Market Analysis - by Service
8.1 Sequence Analysis Platform
8.1.1 Overview
8.1.2 Sequence Analysis Platform: Drug Discovery Informatics Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Molecular Modelling
8.2.1 Overview
8.2.2 Molecular Modelling: Drug Discovery Informatics Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Clinical Trial Data Management
8.3.1 Overview
8.3.2 Clinical Trial Data Management: Drug Discovery Informatics Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Docking
8.4.1 Overview
8.4.2 Docking: Drug Discovery Informatics Market - Revenue and Forecast to 2031 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Drug Discovery Informatics Market - Revenue and Forecast to 2031 (US$ Million)
9. Drug Discovery Informatics Market Analysis - by Solutions
9.1 Software
9.1.1 Overview
9.1.2 Software: Drug Discovery Informatics Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Services
9.2.1 Overview
9.2.2 Services: Drug Discovery Informatics Market - Revenue and Forecast to 2031 (US$ Million)
10. Drug Discovery Informatics Market Analysis - by End User
10.1 Pharmaceutical and Biotechnology Companies
10.1.1 Overview
10.1.2 Pharmaceutical and Biotechnology Companies: Drug Discovery Informatics Market - Revenue and Forecast to 2031 (US$ Million)
10.2 Contract Research Organizations (CROs)
10.2.1 Overview
10.2.2 Contract Research Organizations (CROs): Drug Discovery Informatics Market - Revenue and Forecast to 2031 (US$ Million)
10.3 Others
10.3.1 Overview
10.3.2 Others: Drug Discovery Informatics Market - Revenue and Forecast to 2031 (US$ Million)
11. Drug Discovery Informatics Market - Geographical Analysis
11.1 Overview
11.2 North America
11.2.1 North America Drug Discovery Informatics Market Overview
11.2.2 North America: Drug Discovery Informatics Market - Revenue, 2021-2031 (US$ Million)
11.2.3 North America: Drug Discovery Informatics Market Breakdown, by Workflow
11.2.3.1 North America: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Workflow
11.2.4 North America: Drug Discovery Informatics Market Breakdown, by Service
11.2.4.1 North America: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Service
11.2.5 North America: Drug Discovery Informatics Market Breakdown, by Solutions
11.2.5.1 North America: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Solutions
11.2.6 North America: Drug Discovery Informatics Market Breakdown, by End User
11.2.6.1 North America: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by End User
11.2.7 North America: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Country
11.2.7.1 North America: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Country
11.2.7.2 United States: Drug Discovery Informatics Market - Revenue and Forecast, 2021-2031 (US$ Million)
11.2.7.2.1 United States: Drug Discovery Informatics Market Breakdown, by Workflow
11.2.7.2.2 United States: Drug Discovery Informatics Market Breakdown, by Service
11.2.7.2.3 United States: Drug Discovery Informatics Market Breakdown, by Solutions
11.2.7.2.4 United States: Drug Discovery Informatics Market Breakdown, by End User
11.2.7.3 Canada: Drug Discovery Informatics Market - Revenue and Forecast, 2021-2031 (US$ Million)
11.2.7.3.1 Canada: Drug Discovery Informatics Market Breakdown, by Workflow
11.2.7.3.2 Canada: Drug Discovery Informatics Market Breakdown, by Service
11.2.7.3.3 Canada: Drug Discovery Informatics Market Breakdown, by Solutions
11.2.7.3.4 Canada: Drug Discovery Informatics Market Breakdown, by End User
11.2.7.4 Mexico: Drug Discovery Informatics Market - Revenue and Forecast, 2021-2031 (US$ Million)
11.2.7.4.1 Mexico: Drug Discovery Informatics Market Breakdown, by Workflow
11.2.7.4.2 Mexico: Drug Discovery Informatics Market Breakdown, by Service
11.2.7.4.3 Mexico: Drug Discovery Informatics Market Breakdown, by Solutions
11.2.7.4.4 Mexico: Drug Discovery Informatics Market Breakdown, by End User
11.3 Europe
11.3.1 Europe Drug Discovery Informatics Market Overview
11.3.2 Europe: Drug Discovery Informatics Market - Revenue, 2021-2031 (US$ Million)
11.3.3 Europe: Drug Discovery Informatics Market Breakdown, by Workflow
11.3.3.1 Europe: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Workflow
11.3.4 Europe: Drug Discovery Informatics Market Breakdown, by Service
11.3.4.1 Europe: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Service
11.3.5 Europe: Drug Discovery Informatics Market Breakdown, by Solutions
11.3.5.1 Europe: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Solutions
11.3.6 Europe: Drug Discovery Informatics Market Breakdown, by End User
11.3.6.1 Europe: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by End User
11.3.7 Europe: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Country
11.3.7.1 Europe: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Country
11.3.7.2 Germany: Drug Discovery Informatics Market - Revenue and Forecast, 2021-2031 (US$ Million)
11.3.7.2.1 Germany: Drug Discovery Informatics Market Breakdown, by Workflow
11.3.7.2.2 Germany: Drug Discovery Informatics Market Breakdown, by Service
11.3.7.2.3 Germany: Drug Discovery Informatics Market Breakdown, by Solutions
11.3.7.2.4 Germany: Drug Discovery Informatics Market Breakdown, by End User
11.3.7.3 United Kingdom: Drug Discovery Informatics Market - Revenue and Forecast, 2021-2031 (US$ Million)
11.3.7.3.1 United Kingdom: Drug Discovery Informatics Market Breakdown, by Workflow
11.3.7.3.2 United Kingdom: Drug Discovery Informatics Market Breakdown, by Service
11.3.7.3.3 United Kingdom: Drug Discovery Informatics Market Breakdown, by Solutions
11.3.7.3.4 United Kingdom: Drug Discovery Informatics Market Breakdown, by End User
11.3.7.4 France: Drug Discovery Informatics Market - Revenue and Forecast, 2021-2031 (US$ Million)
11.3.7.4.1 France: Drug Discovery Informatics Market Breakdown, by Workflow
11.3.7.4.2 France: Drug Discovery Informatics Market Breakdown, by Service
11.3.7.4.3 France: Drug Discovery Informatics Market Breakdown, by Solutions
11.3.7.4.4 France: Drug Discovery Informatics Market Breakdown, by End User
11.3.7.5 Italy: Drug Discovery Informatics Market - Revenue and Forecast, 2021-2031 (US$ Million)
11.3.7.5.1 Italy: Drug Discovery Informatics Market Breakdown, by Workflow
11.3.7.5.2 Italy: Drug Discovery Informatics Market Breakdown, by Service
11.3.7.5.3 Italy: Drug Discovery Informatics Market Breakdown, by Solutions
11.3.7.5.4 Italy: Drug Discovery Informatics Market Breakdown, by End User
11.3.7.6 Russia: Drug Discovery Informatics Market - Revenue and Forecast, 2021-2031 (US$ Million)
11.3.7.6.1 Russia: Drug Discovery Informatics Market Breakdown, by Workflow
11.3.7.6.2 Russia: Drug Discovery Informatics Market Breakdown, by Service
11.3.7.6.3 Russia: Drug Discovery Informatics Market Breakdown, by Solutions
11.3.7.6.4 Russia: Drug Discovery Informatics Market Breakdown, by End User
11.3.7.7 Rest of Europe: Drug Discovery Informatics Market - Revenue and Forecast, 2021-2031 (US$ Million)
11.3.7.7.1 Rest of Europe: Drug Discovery Informatics Market Breakdown, by Workflow
11.3.7.7.2 Rest of Europe: Drug Discovery Informatics Market Breakdown, by Service
11.3.7.7.3 Rest of Europe: Drug Discovery Informatics Market Breakdown, by Solutions
11.3.7.7.4 Rest of Europe: Drug Discovery Informatics Market Breakdown, by End User
11.4 Asia Pacific
11.4.1 Asia Pacific Drug Discovery Informatics Market Overview
11.4.2 Asia Pacific: Drug Discovery Informatics Market - Revenue, 2021-2031 (US$ Million)
11.4.3 Asia Pacific: Drug Discovery Informatics Market Breakdown, by Workflow
11.4.3.1 Asia Pacific: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Workflow
11.4.4 Asia Pacific: Drug Discovery Informatics Market Breakdown, by Service
11.4.4.1 Asia Pacific: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Service
11.4.5 Asia Pacific: Drug Discovery Informatics Market Breakdown, by Solutions
11.4.5.1 Asia Pacific: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Solutions
11.4.6 Asia Pacific: Drug Discovery Informatics Market Breakdown, by End User
11.4.6.1 Asia Pacific: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by End User
11.4.7 Asia Pacific: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Country
11.4.7.1 Asia Pacific: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Country
11.4.7.2 China: Drug Discovery Informatics Market - Revenue and Forecast, 2021-2031 (US$ Million)
11.4.7.2.1 China: Drug Discovery Informatics Market Breakdown, by Workflow
11.4.7.2.2 China: Drug Discovery Informatics Market Breakdown, by Service
11.4.7.2.3 China: Drug Discovery Informatics Market Breakdown, by Solutions
11.4.7.2.4 China: Drug Discovery Informatics Market Breakdown, by End User
11.4.7.3 Japan: Drug Discovery Informatics Market - Revenue and Forecast, 2021-2031 (US$ Million)
11.4.7.3.1 Japan: Drug Discovery Informatics Market Breakdown, by Workflow
11.4.7.3.2 Japan: Drug Discovery Informatics Market Breakdown, by Service
11.4.7.3.3 Japan: Drug Discovery Informatics Market Breakdown, by Solutions
11.4.7.3.4 Japan: Drug Discovery Informatics Market Breakdown, by End User
11.4.7.4 India: Drug Discovery Informatics Market - Revenue and Forecast, 2021-2031 (US$ Million)
11.4.7.4.1 India: Drug Discovery Informatics Market Breakdown, by Workflow
11.4.7.4.2 India: Drug Discovery Informatics Market Breakdown, by Service
11.4.7.4.3 India: Drug Discovery Informatics Market Breakdown, by Solutions
11.4.7.4.4 India: Drug Discovery Informatics Market Breakdown, by End User
11.4.7.5 Australia: Drug Discovery Informatics Market - Revenue and Forecast, 2021-2031 (US$ Million)
11.4.7.5.1 Australia: Drug Discovery Informatics Market Breakdown, by Workflow
11.4.7.5.2 Australia: Drug Discovery Informatics Market Breakdown, by Service
11.4.7.5.3 Australia: Drug Discovery Informatics Market Breakdown, by Solutions
11.4.7.5.4 Australia: Drug Discovery Informatics Market Breakdown, by End User
11.4.7.6 South Korea: Drug Discovery Informatics Market - Revenue and Forecast, 2021-2031 (US$ Million)
11.4.7.6.1 South Korea: Drug Discovery Informatics Market Breakdown, by Workflow
11.4.7.6.2 South Korea: Drug Discovery Informatics Market Breakdown, by Service
11.4.7.6.3 South Korea: Drug Discovery Informatics Market Breakdown, by Solutions
11.4.7.6.4 South Korea: Drug Discovery Informatics Market Breakdown, by End User
11.4.7.7 Rest of APAC: Drug Discovery Informatics Market - Revenue and Forecast, 2021-2031 (US$ Million)
11.4.7.7.1 Rest of APAC: Drug Discovery Informatics Market Breakdown, by Workflow
11.4.7.7.2 Rest of APAC: Drug Discovery Informatics Market Breakdown, by Service
11.4.7.7.3 Rest of APAC: Drug Discovery Informatics Market Breakdown, by Solutions
11.4.7.7.4 Rest of APAC: Drug Discovery Informatics Market Breakdown, by End User
11.5 Middle East and Africa
11.5.1 Middle East and Africa Drug Discovery Informatics Market Overview
11.5.2 Middle East and Africa: Drug Discovery Informatics Market - Revenue, 2021-2031 (US$ Million)
11.5.3 Middle East and Africa: Drug Discovery Informatics Market Breakdown, by Workflow
11.5.3.1 Middle East and Africa: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Workflow
11.5.4 Middle East and Africa: Drug Discovery Informatics Market Breakdown, by Service
11.5.4.1 Middle East and Africa: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Service
11.5.5 Middle East and Africa: Drug Discovery Informatics Market Breakdown, by Solutions
11.5.5.1 Middle East and Africa: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Solutions
11.5.6 Middle East and Africa: Drug Discovery Informatics Market Breakdown, by End User
11.5.6.1 Middle East and Africa: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by End User
11.5.7 Middle East and Africa: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Country
11.5.7.1 Middle East and Africa: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Country
11.5.7.2 Arabia: Drug Discovery Informatics Market - Revenue and Forecast, 2021-2031 (US$ Million)
11.5.7.2.1 Saudi Arabia: Drug Discovery Informatics Market Breakdown, by Workflow
11.5.7.2.2 Saudi Arabia: Drug Discovery Informatics Market Breakdown, by Service
11.5.7.2.3 Saudi Arabia: Drug Discovery Informatics Market Breakdown, by Solutions
11.5.7.2.4 Saudi Arabia: Drug Discovery Informatics Market Breakdown, by End User
11.5.7.3 South Africa: Drug Discovery Informatics Market - Revenue and Forecast, 2021-2031 (US$ Million)
11.5.7.3.1 South Africa: Drug Discovery Informatics Market Breakdown, by Workflow
11.5.7.3.2 South Africa: Drug Discovery Informatics Market Breakdown, by Service
11.5.7.3.3 South Africa: Drug Discovery Informatics Market Breakdown, by Solutions
11.5.7.3.4 South Africa: Drug Discovery Informatics Market Breakdown, by End User
11.5.7.4 United Arab Emirates: Drug Discovery Informatics Market - Revenue and Forecast, 2021-2031 (US$ Million)
11.5.7.4.1 United Arab Emirates: Drug Discovery Informatics Market Breakdown, by Workflow
11.5.7.4.2 United Arab Emirates: Drug Discovery Informatics Market Breakdown, by Service
11.5.7.4.3 United Arab Emirates: Drug Discovery Informatics Market Breakdown, by Solutions
11.5.7.4.4 United Arab Emirates: Drug Discovery Informatics Market Breakdown, by End User
11.5.7.5 Rest of Middle East and Africa: Drug Discovery Informatics Market - Revenue and Forecast, 2021-2031 (US$ Million)
11.5.7.5.1 Rest of Middle East and Africa: Drug Discovery Informatics Market Breakdown, by Workflow
11.5.7.5.2 Rest of Middle East and Africa: Drug Discovery Informatics Market Breakdown, by Service
11.5.7.5.3 Rest of Middle East and Africa: Drug Discovery Informatics Market Breakdown, by Solutions
11.5.7.5.4 Rest of Middle East and Africa: Drug Discovery Informatics Market Breakdown, by End User
11.6 South and Central America
11.6.1 South and Central America Drug Discovery Informatics Market Overview
11.6.2 South and Central America: Drug Discovery Informatics Market - Revenue, 2021-2031 (US$ Million)
11.6.3 South and Central America: Drug Discovery Informatics Market Breakdown, by Workflow
11.6.3.1 South and Central America: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Workflow
11.6.4 South and Central America: Drug Discovery Informatics Market Breakdown, by Service
11.6.4.1 South and Central America: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Service
11.6.5 South and Central America: Drug Discovery Informatics Market Breakdown, by Solutions
11.6.5.1 South and Central America: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Solutions
11.6.6 South and Central America: Drug Discovery Informatics Market Breakdown, by End User
11.6.6.1 South and Central America: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by End User
11.6.7 South and Central America: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Country
11.6.7.1 South and Central America: Drug Discovery Informatics Market - Revenue and Forecast Analysis - by Country
11.6.7.2 Brazil: Drug Discovery Informatics Market - Revenue and Forecast, 2021-2031 (US$ Million)
11.6.7.2.1 Brazil: Drug Discovery Informatics Market Breakdown, by Workflow
11.6.7.2.2 Brazil: Drug Discovery Informatics Market Breakdown, by Service
11.6.7.2.3 Brazil: Drug Discovery Informatics Market Breakdown, by Solutions
11.6.7.2.4 Brazil: Drug Discovery Informatics Market Breakdown, by End User
11.6.7.3 Argentina: Drug Discovery Informatics Market - Revenue and Forecast, 2021-2031 (US$ Million)
11.6.7.3.1 Argentina: Drug Discovery Informatics Market Breakdown, by Workflow
11.6.7.3.2 Argentina: Drug Discovery Informatics Market Breakdown, by Service
11.6.7.3.3 Argentina: Drug Discovery Informatics Market Breakdown, by Solutions
11.6.7.3.4 Argentina: Drug Discovery Informatics Market Breakdown, by End User
11.6.7.4 Rest of South and Central America: Drug Discovery Informatics Market - Revenue and Forecast, 2021-2031 (US$ Million)
11.6.7.4.1 Rest of South and Central America: Drug Discovery Informatics Market Breakdown, by Workflow
11.6.7.4.2 Rest of South and Central America: Drug Discovery Informatics Market Breakdown, by Service
11.6.7.4.3 Rest of South and Central America: Drug Discovery Informatics Market Breakdown, by Solutions
11.6.7.4.4 Rest of South and Central America: Drug Discovery Informatics Market Breakdown, by End User
12. Competitive Landscape
12.1 Heat Map Analysis by Key Players
12.2 Company Market Share Analysis, 2024
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Product Development
13.4 Mergers & Acquisitions
13.5 Partnership and Collaboration
13.6 Expansion
14. Company Profiles
14.1 Jubilant Pharma Limited
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Certera
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Thermo Fisher Scientific Inc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Dassault Systemes SE
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Revvity Inc
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Selvita
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Eurofins Scientific SE
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Collaborative Drug Discovery, Inc.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Charles River Laboratories International Inc
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Illumina, Inc
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 List of Abbreviations
관련자료
